|
|
|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
Stakeholder Insight: Diabetes
Type 2 diabetes is an emerging epidemic driven by the escalating prevalence of obesity and by an ageing population. Diagnosis rates will continue to increase as improved awareness raises the public profile of the disease. Despite several established cl
Digestive System - Acidity Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of acidity drugs by company and by stage as well as a summary of the latest news and developments in this area.
Pipeline Insight: Upper GI Disorders - Generics will limit...
Gastroesophageal reflux disease (GERD), functional dyspepsia (FD) and peptic ulcer disease (PUD) represent a group of common gastrointestinal (GI) conditions, which can be referred to collectively as upper GI disorders. Gastric acid suppression remains
Stakeholder Insight: Osteoporosis
This report is based on a survey of 180 physicians across the seven major markets covering key issues in osteopenia and osteoporosis; including epidemiology, presentation, diagnosis and treatment trends, prescribing influences, and brand assessments.<
Commercial Insight: Antidiabetics
In-depth analysis of the current status and future potential of the marketed antidiabetic drug classes. Drug classes covered include sulfonylureas, biguanides, insulin, TZDs, AGIs, prandial glucose regulators and Incretin Mimetics.
Forecast Insight: Dyslipidemia
Analysis of the competitive landscape and the recent changes in antidyslipidemics across seven major markets. Explores the key events that are likely to impact the performance of the antidyslipidemics, and provides sales forecasts to 2017.
Insulin Delivery Systems Market Analysis (2007-2010)
The report investigates the market for various devices used for delivering insulin, including syringes, pens, pumps, needle-free injectors and inhalers. It also takes into account pros and cons of each device and gives a detailed analysis on their futu
Pipeline Insight: Osteoporosis
Analysis of disease-modifying drugs in late-stage clinical development for use in osteoporosis, including important clinical trial results, patient potential, market potential, and forecasts to 2016; supported by key opinion leader comments.
Metabolic Endocrinology - Obesity Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of obesity drugs by company and by stage as well as a summary of the latest news and developments in this area.
Forecast Model: Antidyslipidemics
Region-specific sales value and volume forecasts for marketed dyslipidemia brands and generics in the US, 5EU, and Japan from 2008 to 2017.
Hemophilia or Blood Coagulation Disorders Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of hemophilia or blood coagulation disorders drugs by company and by stage as well as a summary of the latest news and developments in this area.
Obesity Drug Markets in the US and EU
This report explores the dynamics and drivers of the market for current and emerging obesity treatments. This report evaluates the performances and attributes of currently marketed products and highlights the most effective strategies for securing futu
Digestive System - Constipation Drug Pipeline Report
Detailed information on the current drug pipeline. This report provides insight into the pipeline status of constipation drugs by company and by stage as well as a summary of the latest news and developments in this area.
|
